Skip to main content
Dryad logo

The effect of an end-effector type of robot-assisted gait training on patients with Guillain-Barré syndrome

Citation

Jeon, Hara; Rhee, Seung Yeon; Kim, Seong Woo; Lee, June Sung (2020), The effect of an end-effector type of robot-assisted gait training on patients with Guillain-Barré syndrome, Dryad, Dataset, https://doi.org/10.5061/dryad.hqbzkh1df

Abstract

Background: Guillain-Barre syndrome (GBS) is a peripheral nerve injury caused by a post-infectious immune response. Although the prognosis of GBS is relatively good, some patients have severe impairments such as walking disabilities. Robot-assisted gait training (RAGT) is used to improve gait function in various neurologic disorders; however, no studies have reported its effectiveness in GBS patients. We aimed to evaluate the effect of gait training using an end-effector type robotic device on GBS patients.

Methods: This was a retrospective study of patients diagnosed with GBS who received RAGT using Morning Walk® at the inpatient department. The main outcome measures evaluated before and after RAGT were: Medical Research Council scale, Functional Ambulation Categories, Modified Barthel Index score, Rivermead Mobility Index, and 2-minute walk test.

Results: In total, 15 patients underwent RAGT 24 times. The mean age was 55.7 (±15.3) years and the average time from onset was 3.9 (±3.6) months. When compared to the baseline, all outcome measures associated with gait function were improved after RAGT.

Conclusions: RAGT can improve walking ability in GBS patients. RAGT can be considered as one of the gait training tools to recover gait function in GBS patients.

Methods

We retrospectively analysed patients with GBS who treated robotic assisted gait training from April 2016 to January 2020. 

Usage Notes

1. Title of Dataset: The effect of an end-effector type of robot-assisted gait training on patients with Guillain-Barre syndrome

2. File List: RAGT in GBS

3. Number of variables: 23

4. Number of cases/rows: 15

5. Variable List: 
 age: years
 gender: 1(male), 2(female)
 onset: period from the datd of disease onset to the start of treatment
 hipFlx: muscle strength when flexing the hip joint before treatment
   0(zero), 1(trace), 2(poor), 3(fair), 4(good), 5(normal)
 FUhipFlx: muscle strength when flexing the hip joint after treatment
   0(zero), 1(trace), 2(poor), 3(fair), 4(good), 5(normal)
 hipExt: muscle strength when extending the hip joint before treatment
   0(zero), 1(trace), 2(poor), 3(fair), 4(good), 5(normal)
 FUhipExt: muscle strength when extending the hip joint after treatment
   0(zero), 1(trace), 2(poor), 3(fair), 4(good), 5(normal)
 kneeFlx: muscle strength when flexing the knee joint before treatment
   0(zero), 1(trace), 2(poor), 3(fair), 4(good), 5(normal)
 FUkneeFlx: muscle strength when flexing the knee joint after treatment
   0(zero), 1(trace), 2(poor), 3(fair), 4(good), 5(normal)
 kneeExt: muscle strength when extending the knee joint before treatment
   0(zero), 1(trace), 2(poor), 3(fair), 4(good), 5(normal)
 FUkneeExt: muscle strength when extending the knee joint after treatment
   0(zero), 1(trace), 2(poor), 3(fair), 4(good), 5(normal)
 ankleFlx: muscle strength when flexing the ankle joint before treatment
   0(zero), 1(trace), 2(poor), 3(fair), 4(good), 5(normal)
 FUankleFlx: muscle strength when flexing the ankle joint after treatment
   0(zero), 1(trace), 2(poor), 3(fair), 4(good), 5(normal)
 ankleExt: muscle strength when extending the ankle joint before treatment
   0(zero), 1(trace), 2(poor), 3(fair), 4(good), 5(normal)
 FUankleExt: muscle strength when extending the ankle joint after treatment
   0(zero), 1(trace), 2(poor), 3(fair), 4(good), 5(normal)
 FAC: Functional Ambulation Category before treatment
 MBI: Modified Barthel Index before treatment
 TowMin: walking distance for 2 minuites before treatment (units are meter)
 MI: Rivermead Mobility Index before treatment
 fuFAC: Functional Ambulation Category after treatment
 fuMBI: Modified Barthel Index after treatment
 fuTowMin: walking distance for 2 minuites after treatment
 fuMI: Rivermead Mobility Index after treatment